“Psychedelics, used responsibly and with proper caution, would be for psychiatry what the microscope is for biology or the telescope is for astronomy.”
— Stanislav Grof, M.D.
A new standard of care
After decades of prohibition, regulators are re-evaluating the use of psychedelics to advance progress in psychiatry.
Data from late stage FDA clinical trials suggests that psilocybin and MDMA will revolutionize the treatment of depression and PTSD when integrated with psychotherapy.
It’s Novamind’s goal to provide access to these psychedelic medicines and others in safe, regulated settings.
A psychedelic ecosystem
In anticipation of the FDA approving MDMA and psilocybin therapies, Novamind acting as a parent company, is consolidating and investing in specialized treatment infrastructure and resources:
- Ketamine-assisted psychotherapy
For treatment-resistant depression
- Integrated psychiatric care
Innovative, evidence-based treatments
- Legal psilocybin experiences
Retreats in the Netherlands
- Novel IRB approved studies
Psychedelic clinical trials and research
At the forefront of behavioral healthcare innovation.
We are dedicated to advancing psychedelic research and catalyzing personal wellness.
To facilitate safe, legal access to psychedelics
A new standard of mental healthcare
Jesse Kaplan, CFA
Jesse Kaplan has been a partner with Plaza Capital Limited since 2015. His career has focused on advising and investing in early stage growth companies. This has included extensive work helping companies through the process of going public in both Canada and the United States. Jesse was previously a senior analyst at Harborview Advisors LLC, a New York based investment firm and Palladium Capital Advisors, LLC, a NASD member investment bank. Currently, he is a board member of Abacus Health Products (CSE:ABCS) among other successful companies.
Chief Executive Officer & Director
Yaron Conforti is the founder and principal of Emmcap Corp., an investor in venture-stage companies. He previously served in senior investment banking roles at Desjardins Securities and Sandfire Securities and in CEO, CFO and corporate director roles for private and public companies.
Sruli Weinreb is the founder and managing partner of Plaza Capital Limited. Plaza Capital supports many North American early stage growth companies with strategic debt placements and equity investments. He is also the chief executive officer of Lake Central Air Services Inc., the world’s leading modification and integration partner for the airborne geophysical survey industry. Before founding Plaza Capital in 2013, Sruli was the chief executive officer of eMobile Inc., a telecom arbitrage company with a specialization in international roaming which he co-founded in 2008.
VP, Business Development
Prior to Novamind, Nolan was an analyst at First Republic Capital, a Canadian investment bank, where he financed early-stage growth companies with debt and equity private placements. In 2017 he graduated from Dalhousie University where he majored in finance and earned a Bachelor of Commerce. Nolan is also a level III candidate in the CFA program.
- Novamind Sponsors TheraPsil, an Advocate for the Compassionate Use of Psilocybin in Canada
- Novamind Closes the Acquisition of Cedar Psychiatry, a Leading Psychedelic Therapy Organization in the U.S.
- Novamind Announces Closing of Oversubscribed Private Placement